Md Ashiqur Rahman

Mr. Md Ashiqur Rahman

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Preventive Veterinary Medicine
Verified
Journal Article
Closed access
JBJoseph P. Belgrad
Joseph P. Belgrad
MRMd Ashiqur Rahman
Md Ashiqur Rahman
SASadeque Abdullah
Sadeque Abdullah
HRHarun Rashid
Harun Rashid
Md Abu SayeedMd Abu Sayeed
Md Abu Sayeed
MHMd. Ahasanul Hoque
Md. Ahasanul Hoque

18 December 2018 in Tropical Animal Health and Production
Verified
Journal Article
Closed access
PDF file
MRMd Ashiqur Rahman
Md Ashiqur Rahman
MRMahbubur Rahman
Mahbubur Rahman
SASadeque Abdullah
Sadeque Abdullah
Md Abu SayeedMd Abu Sayeed
Md Abu Sayeed
HRHarun Rashid
Harun Rashid
AHAhasanul Hoque
Ahasanul Hoque

30 June 2022 in Veterinary World
Verified
Journal Article
Open access
TMTahura Khanam Munmun
Tahura Khanam Munmun
SIShariful Islam
Shariful Islam
SZShafayat Zamil
Shafayat Zamil
MRMd Ashiqur Rahman
Md Ashiqur Rahman
JAJosefina Abedin
Josefina Abedin
AIAriful Islam
Ariful Islam
Background and Aim: Bluetongue (BT) is a non-contagious, infectious disease of wild and domestic ruminant animals caused by the BT virus (BTV). Bangladesh having a border with a BTV-endemic country, India and a substantial number of susceptible animals. Therefore, this study aimed to estimate BTV seroprevalence and potential risk factors. Materials and Methods: We collected 150 serum samples from indigenous sheep from Chattogram, Bangladesh. We screened the serum samples using a competitive enzyme-linked immunosorbent assay for detecting BTV-specific immunoglobulin. Results: We detected antibodies against BTV in 39.3% (59/150; 95% confidence interval: 31.5–47.6) of all sampled sheep. Factors like sampling site, sheep rearing location, rearing sheep with other farm species, and body condition score had a significant (p < 0.05) influence on the seroprevalence of BTV. Conclusion: The findings show that indigenous sheep have a higher BTV seroprevalence, necessitating sustained surveillance for early diagnosis and a better understanding of virus epidemiology in Bangladesh.

10 March 2026 in Veterinary Microbiology
Verified
Journal Article
Open access
MRMd Ashiqur Rahman
Md Ashiqur Rahman
RARebecca Jane Abraham
Rebecca Jane Abraham
SASam Abraham
Sam Abraham
DHDavid John Hampson
David John Hampson
Jasim Muhammad UddinJasim Muhammad Uddin
Jasim Muhammad Uddin
Bacteriophages (phages) are viruses that infect and may kill bacteria. Phage therapy has gained global attention as a possible means to circumvent problems of bacterial antimicrobial resistance (AMR) in food animal production systems. In preparing this overview on the use of phage therapy in terrestrial food animals, 127 published research articles were analysed to obtain a contemporary background on phage therapy, the efficacy of phage administration, research gaps, and future research directions. Most of the published in vivo trials in chickens described administering phages as biocontrol agents, whereas in vivo trials in pigs administered phages as therapeutics. Only a few trials were conducted in cattle and sheep, targeting foodborne, udder and skin infections. The most common target bacteria in poultry trials were Salmonella Enteritidis, followed by Escherichia coli, Salmonella Typhimurium, Salmonella Pullorum, and Campylobacter jejuni. In contrast, antimicrobial resistant strains of S. Typhimurium and E. coli were the target bacteria in the pig trials. Most studies administered phage cocktails rather than single phage preparation, with bacterial challenge doses varying from 10³ to 10¹⁰ colony forming units (CFU), and phage doses ranging from 10⁵ to 10¹¹ plaque forming units (PFU). In all the reviewed studies phage treatment consistently reduced bacterial load by 0.4-5.0 log₁₀ CFU in feces, meat, and both external and internal organs. Moreover, as a therapeutic, phages were reported to cure diarrhea, improve nutrient digestibility, and enhance weight gain. Phage therapy also reduced specific serum IgG levels against the target bacteria and lowered neutrophil counts and TNF-α concentrations. Together these studies suggest that phage therapy may be an effective treatment approach in controlling certain key infections and hence alleviating bacterial resistance in food animals. Nevertheless, global collaboration and inclusive research on cost-effective production, efficient delivery methods, phage resistance, and host immune responses are essential for overcoming hurdles and facilitating the widespread application of phage therapy in food animals.

8 May 2026 in Viruses
Verified
Journal Article
Open access
PDF file
MRMd Ashiqur Rahman
Md Ashiqur Rahman
RARebecca Jane Abraham
Rebecca Jane Abraham
DHDavid John Hampson
David John Hampson
SASam Abraham
Sam Abraham
Jasim Muhammad UddinJasim Muhammad Uddin
Jasim Muhammad Uddin
Phage therapy has enormous potential in combating bacterial resistance in food animals. However, its application via the oral route remains limited due to challenges associated with the gastrointestinal tract (GIT) environment and a lack of rigorous clinical trial evidence. Therefore, we systematically searched in Google Scholar, PubMed, Scopus, and Web of Science databases following PRISMA guidelines and finally identified 111 articles on oral phage therapy in food animals from where we summarized the key physiological and chemical factors of the gut environment hindering the effectiveness of oral phage therapy (OPT), examined the methods used to evaluate phage stability in the GI environment, and highlighted potential strategies to mitigate these challenges. In addition, we performed quantitative analysis to visualize in vitro pH and thermal stability patterns of phages targeting bacteria isolated from food animals and variability in buffer and incubation period across stability studies. The GIT consists of several anatomically and functionally distinct segments, where complex interactions occur among digestive enzymes, gastric acids, electrolytes, commensal microbiota, and mucosal immune components. The acidic pH of the stomach is a major barrier to successful oral phage delivery. According to our analysis of pH stability testing data from the reviewed studies, most phages targeting antimicrobial-resistant bacteria in food animals remained stable at pH 5–9 and inactivated under highly acidic (pH ≤ 2) or highly alkaline (pH ≥ 11) conditions. In addition, phages are susceptible to high temperatures (above 60 °C), digestive enzymes (e.g., pepsin, trypsin, lipases), bile salts, and host immune responses. Several in vitro laboratory techniques are available to assess phage stability under simulated GI conditions, but variations occur in the assessment protocols. Microencapsulation using alginate and chitosan has been used to protect phages from the adverse GI environment. Additionally, enteric-coated capsules, antacids, co-encapsulation with acid-neutralizing agents, consumption of alkaline water, and daily phage administration are suggested to improve phage survival and efficacy. For the successful clinical implementation of OPT in food animals, future research should focus on elucidating the molecular and physicochemical determinants of phage stability, understanding the humoral immune response to OPT, standardizing laboratory protocol for assessing phage viability, improving the scalability of encapsulation methods, and exploring other potential delivery techniques.

1 January 2025 in Veterinary Medicine International
Verified
Journal Article
Open access
KAKazi Shams Al Arefin
Kazi Shams Al Arefin
EREaftekhar Ahmed Rana
Eaftekhar Ahmed Rana
SISaiful Islam
Saiful Islam
BHBelayet Hossain
Belayet Hossain
MRMd Ashiqur Rahman
Md Ashiqur Rahman
HBHimel Barua
Himel Barua
Coagulase‐positive staphylococci, notably Staphylococcus aureus and Staphylococcus pseudintermedius , are common pathogens that are frequently associated with suppurative infections in companion animals. This cross‐sectional study aimed to investigate the molecular prevalence, antimicrobial resistance profiles, and associated risk factors of S. aureus and S. pseudintermedius carriage in cats. Standard bacteriological procedures as well as the nuc and pse genes specific PCR were performed to isolate and identify the S. aureus and S. pseudintermedius . Methicillin‐resistant S. aureus (MRSA) and methicillin‐resistant S. pseudintermedius (MRSP) were identified by detecting the mec A gene. A total of 251 swab samples were collected from different body sites of 80 cats. The results showed that 24 (30%) and 5 (6.25%) cats carried S. aureus and S. pseudintermedius , respectively. S. aureus isolates exhibited the highest resistance to penicillin (94.29%) and ampicillin (91.5%), while 60% of S. pseudintermedius isolates were resistant to ampicillin, erythromycin, and ciprofloxacin. Thirty‐two (91%) S. aureus isolates and two (40%) S. pseudintermedius isolates demonstrated resistance to ≥ 3 classes of antimicrobials, indicating multidrug resistance (MDR). The prevalence of MRSA was 11.43%, with none of the S. pseudintermedius isolates carrying the mecA gene and neither S. aureus nor S. pseudintermedius harboring the ermA gene. Multivariable logistic regression identified the previous use of antibiotics as a risk factor for S. aureus colonization in cats (odds ratio [OR] 3.84; 95% CI: 1.23–11.95). Cats with otitis externa (OR 46; 95% CI: 3.2–660.4) and steroid use (OR 46; 95% CI: 3.2–660.4) were potential risk factors for S. pseudintermedius carriage. The circulation of MDR isolates, including the detection of MRSA, poses a significant concern for the clinical management of companion animals.